Users of this system, can login to view this document.

Login

Enter the following information to request a copy of the document from the responsible person.

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial